company

MIDT-NORSK BIOVARME AS

7805 NAMSOS

Return on Equity
−24,73 %
Current Ratio
0,46
Debt-to-Equity Ratio
2,95
Key figures (NOK)2022
Revenue496 000
Net Income−161 000
Total Assets3 614 000
Total Equity651 000
Income (NOK)2022
Revenue496 000
Expenditure625 000
Operating Profit−129 000
Financial Income0
Financial Costs78 000
Financial Balance−78 000
Earnings Before Tax−207 000
Tax−46 000
Net Income−161 000
Balance (NOK)2022
Total Fixed Assets3 140 000
Total Current Assets474 000
Total Assets3 614 000
Total Retained Equity−249 000
Total Equity651 000
Total Long-Term Debt1 922 000
Total Current Debt1 041 000
Total Equity and Debt3 614 000
Cash flow (NOK)2022
Sales Income496 000
Other Income0
Revenue496 000
Cost of Goods Sold346 000
Salary Costs0
Depreciation143 000
Impairment0
Expenditure625 000
Operating Profit−129 000
Financial Income0
Financial Costs78 000
Financial Balance−78 000
Dividends0
Net Income−161 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets70 000
Real Eastate3 027 000
Machinery and Plant Facilities0
Fixtures43 000
Total Tangible Assets3 070 000
Total Fiancial Fixed Assets0
Total Fixed Assets3 140 000
Stock0
Total Investments0
Cash, Bank379 000
Total Current Assets474 000
Total Assets3 614 000
Total Equity651 000
Short-Term Group Debt0
Total Long-Term Debt1 922 000
Creditors1 039 000
Unpaid Taxes2 000
Dividends0
Other Current Debt0
Total Current Debt1 041 000
Total Equity and Debt3 614 000
Financial indicators2022
Return on Equity−24,73 %
Debt-to-Equity Ratio2,95
Operating Profit Margin−26,01 %
Current Ratio0,46
Quick Ratio0,46
Equity Ratio0,18
Gross Profit Margin30,24 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English